Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments Jessica J. HopkinsMichael B. Sawyer Review Article 06 June 2018 Pages: 1 - 29
Role of toll-like receptor 4 (TLR4)-mediated interleukin-6 (IL-6) production in chemotherapy-induced mucositis S. KhanHannah R. WardillJ. M. Bowen Review Article 29 May 2018 Pages: 31 - 37
Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer A. A. van ZweedenC. J. van GroeningenHans J. van der Vliet Original Article Open access 25 April 2018 Pages: 39 - 48
Comparison of tumor size assessments in tumor growth inhibition-overall survival models with second-line colorectal cancer data from the VELOUR study Laurent ClaretChristina PentafragkaRene Bruno Original Article 26 April 2018 Pages: 49 - 54
Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer Jessica LeeJohn P. CurtinStephanie V. Blank Original Article 27 April 2018 Pages: 55 - 63
Sunitinib does not acutely alter left ventricular systolic function, but induces diastolic dysfunction Takeshi WadaKentaro AndoAtsushi Sugiyama Original Article 02 May 2018 Pages: 65 - 75
Exposure–response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer Egbert F. SmitEdward B. GaronMaurice Pérol Original Article 02 May 2018 Pages: 77 - 86
UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy Qianqian YuTao ZhangXianglin Yuan Original Article 04 May 2018 Pages: 87 - 98
Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy Nikolai LitviakovMatvey TsyganovJulia Kzhyshkowska Original Article 04 May 2018 Pages: 99 - 109
Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer Taro KobaSeigo MinamiTakashi Kijima Original Article 04 May 2018 Pages: 111 - 117
Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR–TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations Hisao ImaiHiroyuki MinemuraGunma-Ibaraki-Fukushima-Tochigi (GIFT) Group Original Article 08 May 2018 Pages: 119 - 127
Exposure–response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer Peter N. MorcosEveline NueeschFrancois Mercier Original Article Open access 10 May 2018 Pages: 129 - 138
LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas Orsolya RuszOrsolya PappAnna-Mária Tőkés Original Article 16 May 2018 Pages: 139 - 147
Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity Benjamin AnonBérenger LargeauThierry Lecomte Original Article 17 May 2018 Pages: 149 - 157
Bioequivalence study of single-dose lenalidomide capsule vs. Revlimid® capsule in healthy Chinese males Jin WangLu QiXinghe Wang Clinical Trial Report 11 June 2018 Pages: 159 - 164
Reduced dose pegfilgrastim is associated with less bone pain without increased neutropenia: a retrospective study Elyse E. LowerMahmoud CharifMeg Bartelt Short Communication 05 June 2018 Pages: 165 - 170
